SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-20-005439
Filing Date
2020-07-31
Accepted
2020-07-31 16:05:14
Documents
3
Period of Report
2020-07-31
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_073120.htm 8-K 12289
2 PRESS RELEASE exh_991.htm EX-99.1 12391
3 exh991small_1.jpg GRAPHIC 3298
  Complete submission text file 0001171843-20-005439.txt   30453
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-35776 | Film No.: 201065982
SIC: 2834 Pharmaceutical Preparations